cancer treatment

  1. Mvasi, first direct competitor to a billion-dollar cancer drug

    FDA approves Allergan and Amgen's biosimilar of Roche's Avastin.
    • anonymous
    • Thread
    • allergan amgen cancer treatment fda
    • Replies: 1
    • Forum: Allergan

  2. Celgene to present data in ESMO 2017

    Celgene presenting data for Abraxane at ESMO 2017.
    • anonymous
    • Thread
    • cancer treatment celgene oncology
    • Replies: 0
    • Forum: Celgene

  3. FDA halts Celgene

    Celgene forced to pause 5 trials using AstraZeneca’s Imfinzi and full hold on one trial.
    • anonymous
    • Thread
    • cancer treatment celgene drugs fda
    • Replies: 0
    • Forum: Celgene

  4. Cancer drug KEYTRUDA powers Merck's sales

    Merck quarterly profit beat analysts' estimates as demand surged for its oncology drug, Keytruda. Sales of Keytruda nearly tripled to $881 million in the second quarter, beating consensus estimates of $777 million, according to Barclays. First approved in 2014 to treat melanoma, Keytruda has...
    • Jim Rogers
    • Thread
    • cancer treatment merck
    • Replies: 2
    • Forum: Merck

  5. Cancer drug KEYTRUDA powers Merck's sales

    Merck quarterly profit beat analysts' estimates as demand surged for its oncology drug, Keytruda. Sales of Keytruda nearly tripled to $881 million in the second quarter, beating consensus estimates of $777 million, according to Barclays. First approved in 2014 to treat melanoma, Keytruda has...

  6. Celgene/BeiGene collaboration

    Is this deal advantageous for Celgene? BeiGene (ADR) has surged nearly 28% as of now.
    • RobertPhillips900
    • Thread
    • biopharma biotech cancer treatment healthcare immuno-oncology
    • Replies: 1
    • Forum: Celgene
Top Bottom
Back